GENE ONLINE|News &
Opinion
Blog

Regeneron
Funding HHSCOVID-19
U.S. Government Awards $1.4 Billion to Advance COVID Therapies and Vaccines
2023-08-29
Trials & Approvals Hypercholesterolemia
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Partnerships Regeneron
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Trials & Approvals Cervical Cancer
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
Dupixent
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
Trials & Approvals Sanofi
Sanofi and Regeneron Post Positive Results from Child Throat Disease Trial
2022-07-15
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top